Intimation of Conference Call with Investor/Analysts under the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.

Board & Shareholder Meetings View source PDF

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Pharma Limited has informed the stock exchanges about an upcoming conference call with investors and analysts scheduled for 15th May 2025 from 9:30 AM to 10:15 AM IST. The call will discuss the company's Q4 and FY2025 financial results. Dial-in numbers have been provided for participants from India, USA, UK, Singapore, and Hong Kong. This is a standard regulatory disclosure under SEBI Listing Regulations.

Likely market impact

This is a routine procedural announcement and not a material event. Investors should watch for the actual Q4 and FY2025 results, which will be discussed on the call and could influence short-term stock price movement.